Targeting the HIF2–VEGF axis in renal cell carcinoma von Choueiri, Toni K., Kaelin, William G.

Volltext

Systemic Therapy for Metastatic Renal-Cell Carcinoma von Choueiri, Toni K, Motzer, Robert J

Volltext

IL-8 and cancer prognosis on immunotherapy von Bakouny, Ziad, Choueiri, Toni K.

Volltext

COVID-19 and Cancer: Current Challenges and Perspectives von Bakouny, Ziad, Hawley, Jessica E., Choueiri, Toni K., Peters, Solange, Rini, Brian I., Warner, Jeremy L., Painter, Corrie A.

Volltext

A GPX4-dependent cancer cell state underlies the clear-cell morphology and confers sensitivity to ferroptosis von Zou, Yilong, Palte, Michael J., Deik, Amy A., Li, Haoxin, Eaton, John K., Wang, Wenyu, Tseng, Yuen-Yi, Deasy, Rebecca, Kost-Alimova, Maria, Dančík, Vlado, Leshchiner, Elizaveta S., Viswanathan, Vasanthi S., Signoretti, Sabina, Choueiri, Toni K., Boehm, Jesse S., Wagner, Bridget K., Doench, John G., Clish, Clary B., Clemons, Paul A., Schreiber, Stuart L.

Volltext

Metabolic reprogramming in renal cancer: Events of a metabolic disease von Chakraborty, Samik, Balan, Murugabaskar, Sabarwal, Akash, Choueiri, Toni K., Pal, Soumitro

Volltext

Avelumab plus axitinib versus sunitinib in advanced renal cell carcinoma: biomarker analysis of the phase 3 JAVELIN Renal 101 trial von Motzer, Robert J., Robbins, Paul B., Powles, Thomas, Albiges, Laurence, Haanen, John B., Larkin, James, Mu, Xinmeng Jasmine, Ching, Keith A., Uemura, Motohide, Pal, Sumanta K., Alekseev, Boris, Gravis, Gwenaelle, Campbell, Matthew T., Penkov, Konstantin, Lee, Jae Lyun, Hariharan, Subramanian, Wang, Xiao, Zhang, Weidong, Wang, Jing, Chudnovsky, Aleksander, di Pietro, Alessandra, Donahue, Amber C., Choueiri, Toni K.

Volltext

Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma von Braun, David A., Hou, Yue, Bakouny, Ziad, Ficial, Miriam, Sant’ Angelo, Miriam, Forman, Juliet, Ross-Macdonald, Petra, Berger, Ashton C., Jegede, Opeyemi A., Elagina, Liudmilla, Steinharter, John, Sun, Maxine, Wind-Rotolo, Megan, Pignon, Jean-Christophe, Cherniack, Andrew D., Lichtenstein, Lee, Neuberg, Donna, Catalano, Paul, Freeman, Gordon J., Sharpe, Arlene H., McDermott, David F., Van Allen, Eliezer M., Signoretti, Sabina, Wu, Catherine J., Shukla, Sachet A., Choueiri, Toni K.

Volltext

Systemic Treatment of Metastatic Clear Cell Renal Cell Carcinoma in 2018: Current Paradigms, Use of Immunotherapy, and Future Directions von Lalani, Aly-Khan A., McGregor, Bradley A., Albiges, Laurence, Choueiri, Toni K., Motzer, Robert, Powles, Thomas, Wood, Christopher, Bex, Axel

Volltext

Autoimmune Arthropathy and Uveitis as Complications of Programmed Death 1 Inhibitor Treatment von de Velasco, Guillermo, Bermas, Boonie, Choueiri, Toni K.

Volltext

Protein-Rich Rafts in Hybrid Polymer/Lipid Giant Unilamellar Vesicles von Otrin, Nika, Otrin, Lado, Bednarz, Claudia, Träger, Toni K., Hamdi, Farzad, Kastritis, Panagiotis L., Ivanov, Ivan, Sundmacher, Kai

Volltext

Cabozantinib versus sunitinib as initial therapy for metastatic renal cell carcinoma of intermediate or poor risk (Alliance A031203 CABOSUN randomised trial): Progression-free surv... von Choueiri, Toni K., Hessel, Colin, Halabi, Susan, Sanford, Ben, Michaelson, M. Dror, Hahn, Olwen, Walsh, Meghara, Olencki, Thomas, Picus, Joel, Small, Eric J., Dakhil, Shaker, Feldman, Darren R., Mangeshkar, Milan, Scheffold, Christian, George, Daniel, Morris, Michael J.

Volltext

Evolving Systemic Treatment Landscape for Patients With Advanced Renal Cell Carcinoma von McKay, Rana R, Bossé, Dominick, Choueiri, Toni K

Volltext

Beyond conventional immune-checkpoint inhibition — novel immunotherapies for renal cell carcinoma von Braun, David A., Bakouny, Ziad, Hirsch, Laure, Flippot, Ronan, Van Allen, Eliezer M., Wu, Catherine J., Choueiri, Toni K.

Volltext

Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma von Miao, Diana, Margolis, Claire A, Gao, Wenhua, Voss, Martin H, Li, Wei, Martini, Dylan J, Norton, Craig, Bossé, Dominick, Wankowicz, Stephanie M, Cullen, Dana, Horak, Christine, Wind-Rotolo, Megan, Tracy, Adam, Giannakis, Marios, Hodi, Frank Stephen, Drake, Charles G, Ball, Mark W, Allaf, Mohamad E, Snyder, Alexandra, Hellmann, Matthew D, Ho, Thai, Motzer, Robert J, Signoretti, Sabina, Kaelin, Jr, William G, Choueiri, Toni K, Van Allen, Eliezer M

Volltext

Marital Status and Survival in Patients With Cancer von AIZER, Ayal A, CHEN, Ming-Hui, HU, Jim C, NGUYEN, Paul L, MCCARTHY, Ellen P, MENDU, Mallika L, KOO, Sophia, WILHITE, Tyler J, GRAHAM, Powell L, CHOUEIRI, Toni K, HOFFMAN, Karen E, MARTIN, Neil E

Volltext

Change in Neutrophil-to-lymphocyte Ratio in Response to Targeted Therapy for Metastatic Renal Cell Carcinoma as a Prognosticator and Biomarker of Efficacy von Templeton, Arnoud J, Knox, Jennifer J, Lin, Xun, Simantov, Ronit, Xie, Wanling, Lawrence, Nicola, Broom, Reuben, Fay, André P, Rini, Brian, Donskov, Frede, Bjarnason, Georg A, Smoragiewicz, Martin, Kollmannsberger, Christian, Kanesvaran, Ravindran, Alimohamed, Nimira, Hermanns, Thomas, Wells, J. Connor, Amir, Eitan, Choueiri, Toni K, Heng, Daniel Y.C

Volltext

Lenvatinib plus Pembrolizumab for Renal Cell Carcinoma. Reply von Motzer, Robert, Choueiri, Toni K

Volltext

Perioperative immunotherapy for renal cell carcinoma: looking beyond the data von Labaki, Chris, Choueiri, Toni K.

Volltext

Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures von Şenbabaoğlu, Yasin, Gejman, Ron S, Winer, Andrew G, Liu, Ming, Van Allen, Eliezer M, de Velasco, Guillermo, Miao, Diana, Ostrovnaya, Irina, Drill, Esther, Luna, Augustin, Weinhold, Nils, Lee, William, Manley, Brandon J, Khalil, Danny N, Kaffenberger, Samuel D, Chen, Yingbei, Danilova, Ludmila, Voss, Martin H, Coleman, Jonathan A, Russo, Paul, Reuter, Victor E, Chan, Timothy A, Cheng, Emily H, Scheinberg, David A, Li, Ming O, Choueiri, Toni K, Hsieh, James J, Sander, Chris, Hakimi, A Ari

Volltext